CD44 is a proapoptotic factor in FAS mediated apoptosis in sarcoma cells [112], but is also connected to cancer drug resistance [113].CD44 has successfully been used as a target for liposomal encapsuled doxorubicin [114]. Here, FAS is linked to cancer.